The opportunity to present new ideas and original research in dermatology to the Dermatology Innovation Symposium™ attendees is an integral part of the conference’s continuing medical education program. Encore abstracts/posters are permitted. Posters will be displayed on poster boards in the meeting space and listed on the DIS website until June 30, 2024.
Poster submission is a 2-step process:
The top 3 posters will be selected for a 10-minute oral presentation during a 30-minute poster session. There will be a break with poster authors on Saturday, September 9 from 9:45 am - 10:30 am. At least one author for each poster must be present and next to the poster during this break.
Abstract Submission Rules & Guidelines
Submission deadline: 11:59pm Pacific Time on August 25, 2023. After this date/time, the submissions site will close automatically and can no longer accept submissions. There will be no exceptions to this policy.
Abstract submission fee: The fee is $675 per abstract. Each abstract must be submitted separately. There is no limit on the number of abstracts a company may submit. Payment is required upon submission of this form. The fee is non- refundable unless your abstract is not accepted, in which case you will receive a full refund.
Format: Abstracts must be submitted as .pdf documents on the DIS website (www.dermrefoundation.org).
File name: must include supporting company name and lead author’s last name.
Margins: 1-inch top, bottom, left and right, single spaced; laser printer quality.
Font: font size must be 12-point Times Roman.
Length: 500 words max. inclusive of title, author and affiliations. Abstracts should be a maximum of one 8.5” x 11” page.
Content: Abstracts should reflect content of the poster and must include the poster title. Abstracts should contain the following: a) introduction that states the purpose of the study; b) brief description of the procedure/study; c) brief description of the results; and d) conclusion. Tables/illustrations may not be included in abstracts.
Brand Names: Generic or scientific names of drugs/devices should be used in place of brand names. If brand name is necessary to understand poster content, it should be used only once (after the first mention of the drug or device’s name). Pharmaceutical or other support of any study should be acknowledged at the end of the abstract and at the end of the poster.
Copyright: Copyright is shared. The Dermatology Research and Education Foundation owns copyright for its own use. Author(s) retain the rights for all other uses. Please allow up to one week from date of submission for notification of approval or denial.
If you wish to have your poster posted on the DIS website ONLY, the fee is $550 per abstract.
Pricing is available if interested in additional features such as uploading to the DIS website: audio slides, audio files/commentaries, or author videos of presentations.
Poster submission is a 2-step process:
- All abstracts will be submitted electronically via the Dermatology Innovation Symposium™ website. Send an abstract of the study by August 25, 2023, which will be reviewed and accepted based on scientific value and educational need. Abstracts may only be submitted by dermatologists, dermatology residents, and dermatology researchers at universities, medical schools, pharmaceutical companies, or in private practice.
- If approved, the abstract will be shared at the conference as a poster. Poster submissions of approved abstracts are electronically due on September 1, 2023.
The top 3 posters will be selected for a 10-minute oral presentation during a 30-minute poster session. There will be a break with poster authors on Saturday, September 9 from 9:45 am - 10:30 am. At least one author for each poster must be present and next to the poster during this break.
Abstract Submission Rules & Guidelines
Submission deadline: 11:59pm Pacific Time on August 25, 2023. After this date/time, the submissions site will close automatically and can no longer accept submissions. There will be no exceptions to this policy.
Abstract submission fee: The fee is $675 per abstract. Each abstract must be submitted separately. There is no limit on the number of abstracts a company may submit. Payment is required upon submission of this form. The fee is non- refundable unless your abstract is not accepted, in which case you will receive a full refund.
Format: Abstracts must be submitted as .pdf documents on the DIS website (www.dermrefoundation.org).
File name: must include supporting company name and lead author’s last name.
Margins: 1-inch top, bottom, left and right, single spaced; laser printer quality.
Font: font size must be 12-point Times Roman.
Length: 500 words max. inclusive of title, author and affiliations. Abstracts should be a maximum of one 8.5” x 11” page.
Content: Abstracts should reflect content of the poster and must include the poster title. Abstracts should contain the following: a) introduction that states the purpose of the study; b) brief description of the procedure/study; c) brief description of the results; and d) conclusion. Tables/illustrations may not be included in abstracts.
Brand Names: Generic or scientific names of drugs/devices should be used in place of brand names. If brand name is necessary to understand poster content, it should be used only once (after the first mention of the drug or device’s name). Pharmaceutical or other support of any study should be acknowledged at the end of the abstract and at the end of the poster.
Copyright: Copyright is shared. The Dermatology Research and Education Foundation owns copyright for its own use. Author(s) retain the rights for all other uses. Please allow up to one week from date of submission for notification of approval or denial.
If you wish to have your poster posted on the DIS website ONLY, the fee is $550 per abstract.
Pricing is available if interested in additional features such as uploading to the DIS website: audio slides, audio files/commentaries, or author videos of presentations.
Poster Submission Guidelines
Submission deadline: 11:59pm Pacific Time on September 1, 2023
Content: Poster content should be organized into background, objective, methods, results, and conclusion. Inclusion of graphs, tables and other visual is strongly recommended to enhance engagement. Include all authors and affiliations. All authors must disclose financial relationships. One author is required to register for the conference. The poster should be PDF format.
Poster Formatting Guidelines:
Commercialism: Any display at the Dermatology Innovation Symposium in which cost is underwritten by a pharmaceutical company or other entity must avoid commercialism. Drugs, instrumentation, or devices must not use brand names. If such situations occur, the author/exhibitor is responsible for identifying and clearly stating on the poster that a portion or portions of the cost were provided by the commercial company named.
Submission deadline: 11:59pm Pacific Time on September 1, 2023
Content: Poster content should be organized into background, objective, methods, results, and conclusion. Inclusion of graphs, tables and other visual is strongly recommended to enhance engagement. Include all authors and affiliations. All authors must disclose financial relationships. One author is required to register for the conference. The poster should be PDF format.
Poster Formatting Guidelines:
- The printed posters will be displayed on a poster board that is 96" W x 48" H in size. Posters must be printed to fit the poster board accordingly and it is recommended to print the poster to be 7'9 W x 3'9 H.
- The posters will be available on the website after the meeting and must be formatted to 1920 W x 1080 H in size, landscape orientation and in PDF format.
Commercialism: Any display at the Dermatology Innovation Symposium in which cost is underwritten by a pharmaceutical company or other entity must avoid commercialism. Drugs, instrumentation, or devices must not use brand names. If such situations occur, the author/exhibitor is responsible for identifying and clearly stating on the poster that a portion or portions of the cost were provided by the commercial company named.